Weekly Research Email
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, with a focus on treating conditions affecting the... more
See related posts on Alphatec Spine, Inc.
Did a colleague forward this email to you?
Get your own by signing up here ».
Integra LifeSciences this morning announced plans to acquire the Theken family of businesses - Theken Spine, Theken Disc and Therics - for $75.0 million (a 2.2x revenue multiple) plus up to $125.0 million in future performance-based payments. This acquisition represents... more
See related posts on M&A Activity | Spine
CMS proposed a national non-coverage decision for intradiscal electrothermic therapy (IDET), saying there is insufficient evidence that the procedure improves outcomes in the Medicare population. IDET is a minimally-invasive treatment for low back pain where a catheter and a heating... more
See related posts on Reimbursement | Spine
Zimmer's announced yesterday that they would voluntarily suspend sales of the Durom Acetabular Component in the U.S. while they update the labeling and conduct further surgeon training on the product. As a result, the company is lowering full-year revenue guidance... more
See related posts on Hip | Zimmer
ArthroCare's stock was off almost 40% in midday training following an announcement this morning that the company would restate financials from 2006, 2007 and 1Q:08. The restatement stems from a number of issues, including how revenue from DiscoCare was classified,... more
See related posts on Arthrocare
A study published in the July 14, 2008 issue of Archives of Internal Medicine contends that hip and knee arthroplasty surgeries may be more beneficial to elderly patients than once believed. The study reports that surgery is not only more... more
See related posts on Clinical Studies | Hip | Knee | Trends
On Tuesday, we attended the FDA's Orthopaedic & Rehabilitative Devices Panel, Oxiplex/SP was voted "Not Approvable" by a 5-2 vote, based largely on the sponsoring company's inability to definitively demonstrate product effectiveness. The two dissenters would have voted it "Approvable... more
See related posts on Biologics | Clinical Studies | FDA | Research Studies | Spine
|
Conference Calendar
July 18-19 - Sisyphean Spinal Sociey Annual Meeting
July 25-30 - National Dental Association 95th Annual Convention
Complete Calendar »
Earnings Calendar
Jul 23 @ 9:00 AM ET - Anika Therapeutics, Inc.
Jul 24 @ 8:00 AM ET - Zimmer Holdings, Inc.
Complete Calendar »
|
This communication is neither an offer to sell nor a solicitation of an offer to buy any securities nor is it any form of investment recommendation. The information contained herein has been obtained from sources that we believe to be reliable but we do not guarantee its accuracy or completeness. HealthpointCapital, and/or affiliates may have a position in the securities of the company or companies described herein. Available information supporting this report will be furnished upon request. This report is not directed to, nor is it intended for distribution to or for use by any person or entity who is a citizen or resident or located in any state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject HealthpointCapital, or its affiliates to any registration or licensing requirement within such jurisdiction. HealthpointCapital may seek to provide consulting services for the companies mentioned herein.
